# Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

> **NCT00513162** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Neuroectodermal Tumor
- Brain Metastases
- Advanced Cancer

## Interventions

- **DRUG:** Valproate
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT00513162
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00513162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00513162, "Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00513162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*